Abstract
Respiratory involvement is common in myotonic dystrophy (DM), and respiratory failure is the leading cause of death in DM. DM is associated with a slowly progressive impairment of lung function. Respiratory function is serially assessed by measuring the vital capacity, oxyhemoglobin saturation, peak cough flow, and end-tidal CO2 level. Sleep-disordered breathing (SDB) is also common in DM, including obstructive and/or central sleep apnea and nocturnal hypoventilation. In DM, excessive daytime sleepiness (EDS) is not necessarily attributable to SDB, and it might be caused by a dysfunction in central sleep regulation. The respiratory insufficiency is caused by the combination of muscle impairment and altered central ventilatory control. For the treatment of respiratory failure, noninvasive ventilation (NIV) is recommended, but it might be hampered by cognitive impairment, altered personality, and unawareness of the disease. Improving compliance of the NIV is essential for enhancing the effectiveness of treatment for these patients. In addition, there are various factors that exacerbate respiratory failure, including ineffective airway clearance, infection, obesity, and perioperative pulmonary complication. Multidisciplinary care should be provided for the successful management of these respiratory complications.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Harley HG, Rundle SA, MacMillan JC, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet. 1993;52:1164–74.
de Die-Smulders CE, Howeler CJ, Thijs C, et al. Age and causes of death in adult-onset myotonic dystrophy. Brain. 1998;121:1557–63.
Kuru S. [Respiratory management in muscular dystrophies]. Brain Nerve. 2011;63:1229–36. [Article in Japanese].
Thil C, Agrinier N, Chenuel B, Poussel M. Longitudinal course of lung function in myotonic dystrophy type 1. Muscle Nerve. 2017;56:816–8.
Monteiro R, Bento J, Gonçalves MR, Pinto T, Winck JC. Genetics correlates with lung function and nocturnal ventilation in myotonic dystrophy. Sleep Breath. 2013;17:1087–92.
Sansone VA, Gagnon C, Participants of the 207th ENMC Workshop. 207th ENMC workshop on chronic respiratory insufficiency in myotonic dystrophies: management and implications for research, 27–29 June 2014, Naarden, The Netherlands. Neuromuscul Disord. 2015;25:432–42.
Perrin C, Unterborn JN, Ambrosio CD, Hill NS. Pulmonary complications of chronic neuromuscular diseases and their management. Muscle Nerve. 2004;29:5–27.
Hansotia P, Frens D. Hypersomnia associated with alveolar hypoventilation in myotonic dystrophy. Neurology. 1981;31:1336–7.
Cirignotta F, Mondini S, Zucconi M, et al. Sleep-related breathing impairment in myotonic dystrophy. J Neurol. 1987;235:80–5.
Gibbs JW III, Ciafaloni E, Radtke RA. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep. 2002;25:662–5.
Laberge L, Bégin P, Montplaisir J, Mathieu J. Sleep complaints in patients with myotonic dystrophy. J Sleep Res. 2004;13:95–100.
Park JD, Radtke RA. Hypersomnolence in myotonic dystrophy: demonstration of sleep onset REM sleep. J Neurol Neurosurg Psychiatry. 1995;58:512–3.
Rubinsztein JS, Rubinsztein DC, Goodburn S, Holland AJ. Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry. 1998;64:510–5.
O’Donoghue FJ, Borel JC, Dauvilliers Y, Levy P, Tamisier R, Pépin JL. Effects of 1-month withdrawal of ventilatory support in hypercapnic myotonic dystrophy type 1. Respirology. 2017;22:1416–22.
Poussel M, Thil C, Kaminsky P, et al. Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: evidence for a dysregulation at central level. Neuromuscul Disord. 2015;25:403–8.
Ono S, Takahashi K, Jinnai K, et al. Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia. Neurology. 1998;50:535–8.
Ono S, Takahashi K, Jinnai K, et al. Loss of catecholaminergic neurons in the medullary reticular formation in myotonic dystrophy. Neurology. 1998;51:1121–4.
Martínez-Rodríguez JE, Lin L, Iranzo A, et al. Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Sleep. 2003;26:287–90.
Talbot K, Stradling J, Crosby J, Hilton-Jones D. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. Neuromuscul Disord. 2003;13:357–64.
Fromageot C, Lofaso F, Annane D, et al. Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil. 2001;82:123–8.
Bach JR, Ishikawa Y, Kim H. Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest. 1997;112:1024–8.
Zifko UA, Hahn AF, Remtulla H, et al. Central and peripheral respiratory electrophysiological studies in myotonic dystrophy. Brain. 1996;119:1911–22.
Jammes Y, Pouget J, Grimaud C, Serratrice G. Pulmonary function and electromyographic study of respiratory muscles in myotonic dystrophy. Muscle Nerve. 1985;8:586–94.
Banach M, Antczak J, Rola R. Association of peripheral neuropathy with sleep-related breathing disorders in myotonic dystrophies. Neuropsychiatr Dis Treat. 2017;13:133–40.
Panaite PA, Kuntzer T, Gourdon G, Lobrinus JA, Barakat-Walter I. Functional and histopathological identification of the respiratory failure in a DMSXL transgenic mouse model of myotonic dystrophy. Dis Model Mech. 2013;6:622–31.
Carroll JE, Zwillich CW, Weil JV. Ventilatory response in myotonic dystrophy. Neurology. 1977;27:1125–8.
Serisier DE, Mastaglia FL, Gibson GJ. Respiratory muscle function and ventilatory control. I in patients with motor neurone disease. II in patients with myotonic dystrophy. Q J Med. 1982;51:205–26.
Veale D, Cooper BG, Gilmartin JJ, Walls TJ, Griffith CJ, Gibson GJ. Breathing pattern awake and asleep in patients with myotonic dystrophy. Eur Respir J. 1995;8:815–8.
Finnimore AJ, Jackson RV, Morton A, Lynch E. Sleep hypoxia in myotonic dystrophy and its correlation with awake respiratory function. Thorax. 1994;49:66–70.
van der Meché FG, Bogaard JM, van der Sluys JC, Schimsheimer RJ, Ververs CC, Busch HF. Daytime sleep in myotonic dystrophy is not caused by sleep apnoea. J Neurol Neurosurg Psychiatry. 1994;57:626–8.
Gilmartin JJ, Cooper BG, Griffiths CJ, et al. Breathing during sleep in patients with myotonic dystrophy and non-myotonic respiratory muscle weakness. Q J Med. 1991;78:21–31.
Laberge L, Bégin P, Dauvilliers Y, et al. A polysomnographic study of daytime sleepiness in myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry. 2009;80(6):642.
Kiyan E, Okumus G, Cuhadaroglu C, Deymeer F. Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness. Sleep Breath. 2010;14:19–24.
Kumar SP, Sword D, Petty RK, Banham SW, Patel KR. Assessment of sleep studies in myotonic dystrophy. Chron Respir Dis. 2007;4:15–8.
Pincherle A, Patruno V, Raimondi P, et al. Sleep breathing disorders in 40 Italian patients with myotonic dystrophy type 1. Neuromuscul Disord. 2012;22:219–24.
Romigi A, Albanese M, Ligouri C, et al. Sleep-wake cycle and daytime sleepiness in the myotonic dystrophies. J Neurodegener Dis. 2013;2013:692026.
Gallais B, Gagnon C, Mathieu J, et al. Cognitive deficit associated with sleep apnea in myotonic dystrophy. J Neuromuscul Dis. 2014;1:95–8.
Cao MT, George CFP, Guilleminault C. Sleep and neuromuscular diseases. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine (Chapter 89). 5th ed. Philadelphia, PA: Saunders; 2017. p. 1017–25.
Phillipson EA. Sleep disorders. In: Murray JF, Nadel JA, editors. Textbook of respiratory medicine. 4th ed. Philadelphia: WB Saunders; 2005. p. 2095.
Freyermuth F, Rau F, Kokunai Y, et al. Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy. Nat Commun. 2016;7:11067.
Lazarus A, Varin J, Jauvert G, Alonso C, Duboc D. Relationship between cardiac arrhythmias and sleep apnoea in permanently paced patients with type I myotonic dystrophy. Neuromuscul Disord. 2007;17:392–9.
Canessa N, Castronovo V, Cappa SF, et al. Obstructive sleep apnea: brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183:1419–26.
Gagnon K, Baril AA, Gagnon JF, et al. Cognitive impairment in obstructive sleep apnea. Pathol Biol (Paris). 2014;62:233–40.
Broughton R, Stuss D, Kates M, Roberts J, Dunham W. Neuropsychological deficits and sleep in myotonic dystrophy. Can J Neurol Sci. 1990;17:410–5.
Zalonis I, Bonakis A, Christidi F, et al. Toward understanding cognitive impairment in patients with myotonic dystrophy type 1. Arch Clin Neuropsychol. 2010;25:303–13.
Toussaint M, De Win H, Steens M, Soudon P. Effect of intrapulmonary percussive ventilation on mucus clearance in Duchenne muscular dystrophy patients: a preliminary report. Respir Care. 2003;48:940–7.
Wood L, Cordts I, Atalaia A, et al. The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research. J Neurol. 2017;264:1271–80.
Nugent AM, Smith IE, Shneerson JM. Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest. 2002;121:459–64.
Akamine RT, Grossklauss LF, Moreira GA, et al. Treatment of sleep central apnea with non-invasive mechanical ventilation with 2 levels of positive pressure (bilevel) in a patient with myotonic dystrophy type 1. Sleep Sci. 2014;7:117–21.
Guilleminault C, Philip P, Robinson A. Sleep and neuromuscular disease: bilevel positive airway pressure by nasal mask as a treatment for sleep disordered breathing in patients with neuromuscular disease. J Neurol Neurosurg Psychiatry. 1998;65:225–32.
Agency for Clinical innovation (ACI) Respiratory Network. Domiciliary non-invasive ventilation in adult patients. A consensus statement. 2012. p. 1–172.
Boussaïd G, Lofaso F, Santos DB, et al. Factors influencing compliance with non-invasive ventilation at long-term in patients with myotonic dystrophy type 1: a prospective cohort. Neuromuscul Disord. 2016;26:666–74.
Baldanzi S, Bevilacqua F, Lorio R, et al. Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study. Orphanet J Rare Dis. 2016;11:34.
Seijger CGW, Drost G, Posma JM, et al. Overweight is an independent risk factor for reduced lung volumes in myotonic dystrophy. PLoS One. 2016;11:e0152344.
Mathieu J, Allard P, Gobeil G, Girard M, De Braekeleer M, Bégin P. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology. 1997;49:1646–50.
Acknowledgments
I wish to thank Dr. Fumihiko Yasuma for critically reading the manuscript. This work was partly supported by grants from the Ministry of Health, Labour and Welfare of Japan (H28-Nanchitou(Nan)-Ippan-030) and Japan Agency for Medical Research and Development (AMED) (17ek0109259).
Disclosures: Satoshi Kuru declares no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kuru, S. (2018). Respiratory Feature in Myotonic Dystrophy. In: Takahashi, M., Matsumura, T. (eds) Myotonic Dystrophy. Springer, Singapore. https://doi.org/10.1007/978-981-13-0508-5_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-0508-5_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0507-8
Online ISBN: 978-981-13-0508-5
eBook Packages: MedicineMedicine (R0)